These press releases are intended for business journalists and analysts/investors
GSK has the utmost sympathy for the people who have been, and are, afflicted by arachnoiditis. It can be a very debilitating and painful condition.
Arachnoiditis has a range of possible causes such as spinal injury, surgery and infection. However, it is difficult to determine the causality of arachnoiditis.
Read more - Statement on arachnoiditis and myelograms Read more
Read more - Availability of Menveo (meningococcal ACWY vaccine) Read more
Read more - Bexsero® (Meningococcal B) vaccine availability Read more
Read more - GSK discloses $28,375 in payments to HCPs Read more
Read more - GSK increases supply of Menningococcal B vaccine Read more
Read more - New research shows Australians aren’t taking ageing lying down Read more
Read more - Luke Miels appointed President, Global Pharmaceuticals, GSK Read more
First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS
What would happen to Christmas if Santa suffered prostate issues?
#SeatsUpForSanta social initiative puts spotlight on enlarged prostate symptoms
Read more - Santa’s prostate nightmare urges Australian men to act Read more